You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    Volume 21, Issue 1 (January 1976)

    Two Anaphylactic Deaths After Chemonucleolysis

    (Received 19 May 1975; accepted 6 June 1975)

    Published Online: 1976


      Format Pages Price  
    PDF (368K) 4 $25   ADD TO CART

    Cite this document

    X Add email address send
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    Prior to the early 1960s, treatment of low back pain ascribed to discogenic disease was a choice between a conservative, nonsurgical regime of rest, physiotherapy, and supportive measures, or laminectomy. In 1963, Smith began to inject the drug chymopapain into lumbar disks in patients with low back pain and sciatica [1]. This procedure is now called chemonucleolysis. The purpose of such injections is to depolymerize the cementing protein of the chondromucoprotein complex, reducing the molecular size and viscosity of the nucleus pulposus, thus chemically decompressing the disk space [2]. Anaphylaxis after the injection of chymopapain has been reported [3–6]. The two cases herein reported, however, are the only known deaths due to anaphylaxis.

    Author Information:

    DiMaio, VJM
    Assistant professor, University of Texas Health Sciences Center at Dallas and medical examiner, Institute of Forensic Sciences, Dallas, Tex.

    Stock #: JFS10352J


    DOI: 10.1520/JFS10352J

    Title Two Anaphylactic Deaths After Chemonucleolysis
    Symposium ,
    Committee E30